The Path Analysis in Weight loss, Insulin, and Metabolic Syndrome Factors ─Based on Xenical
碩士 === 國立屏東教育大學 === 應用數學系 === 99 === This research aims to find out the results taking Xenical for 12 weeks and 24 weeks. The research findings will be discussed in this paper is a path analysis in four exogenous variables (two different hospitals, teams, genders, and the first week data) effect the...
Main Authors: | , |
---|---|
Other Authors: | |
Format: | Others |
Language: | zh-TW |
Published: |
2011
|
Online Access: | http://ndltd.ncl.edu.tw/handle/se9yjb |
id |
ndltd-TW-099NPTT5507003 |
---|---|
record_format |
oai_dc |
spelling |
ndltd-TW-099NPTT55070032018-04-10T17:13:53Z http://ndltd.ncl.edu.tw/handle/se9yjb The Path Analysis in Weight loss, Insulin, and Metabolic Syndrome Factors ─Based on Xenical 減重與胰島素及代謝症候群因子之路徑分析─以羅氏鮮為例 Hsiao-Feng Hsieh 謝曉楓 碩士 國立屏東教育大學 應用數學系 99 This research aims to find out the results taking Xenical for 12 weeks and 24 weeks. The research findings will be discussed in this paper is a path analysis in four exogenous variables (two different hospitals, teams, genders, and the first week data) effect the metabolism symptom groups which include insulin, triglyceride, low density cholesterol, high density cholesterol, total cholesterol, uric acid, systolic pressure and diastolic pressure. After taking Xenical for 12 weeks, five results will show in this paper. First, taking Xenical is helpful to decrease the BMI, low density cholesterol, total cholesterol and systolic pressure. Second, the finding says the effects in females are better than males. Based upon the data, females can decrease insulin, triglyceride and uric acid. Third, hospital B is better than hospital A in the decrease of BMI. Fourth, hospital A in controlling high density cholesterol is better than hospital B. The data in 12 week will be decreased if you compare with the data in first week. That is, the more you take Xenical, the lower data in four exogenous variables will be demonstrated. Fourth, the less in uric acid you have, and the less high density cholesterol you get. Fifth, if you decrease the BMI, your systolic pressure will also become lower. Taking Xenical for 24 weeks, the research finding shows it gets lower in BMI, low density cholesterol and total cholesterol. Second, the data indicate triglyceride and uric acid in females are lower than males. Third, the insulin in hospital B lower than hospital A. Fourth, hospital A is superior to hospital B in decreasing the high density cholesterol. The data in 24 week are decreasing if you compare with the data in first week. However, two important findings challenge our thinking. One is the more you decrease in BMI, the lower data you get in insulin. The other is the lower you decrease in insulin, the lower data you diminish your uric acid. Tien-Lung Tsai 蔡典龍 2011 學位論文 ; thesis 88 zh-TW |
collection |
NDLTD |
language |
zh-TW |
format |
Others
|
sources |
NDLTD |
description |
碩士 === 國立屏東教育大學 === 應用數學系 === 99 === This research aims to find out the results taking Xenical for 12 weeks and 24 weeks. The research findings will be discussed in this paper is a path analysis in four exogenous variables (two different hospitals, teams, genders, and the first week data) effect the metabolism symptom groups which include insulin, triglyceride, low density cholesterol, high density cholesterol, total cholesterol, uric acid, systolic pressure and diastolic pressure.
After taking Xenical for 12 weeks, five results will show in this paper. First, taking Xenical is helpful to decrease the BMI, low density cholesterol, total cholesterol and systolic pressure. Second, the finding says the effects in females are better than males. Based upon the data, females can decrease insulin, triglyceride and uric acid. Third, hospital B is better than hospital A in the decrease of BMI. Fourth, hospital A in controlling high density cholesterol is better than hospital B. The data in 12 week will be decreased if you compare with the data in first week. That is, the more you take Xenical, the lower data in four exogenous variables will be demonstrated. Fourth, the less in uric acid you have, and the less high density cholesterol you get. Fifth, if you decrease the BMI, your systolic pressure will also become lower.
Taking Xenical for 24 weeks, the research finding shows it gets lower in BMI, low density cholesterol and total cholesterol. Second, the data indicate triglyceride and uric acid in females are lower than males. Third, the insulin in hospital B lower than hospital A. Fourth, hospital A is superior to hospital B in decreasing the high density cholesterol. The data in 24 week are decreasing if you compare with the data in first week. However, two important findings challenge our thinking. One is the more you decrease in BMI, the lower data you get in insulin. The other is the lower you decrease in insulin, the lower data you diminish your uric acid.
|
author2 |
Tien-Lung Tsai |
author_facet |
Tien-Lung Tsai Hsiao-Feng Hsieh 謝曉楓 |
author |
Hsiao-Feng Hsieh 謝曉楓 |
spellingShingle |
Hsiao-Feng Hsieh 謝曉楓 The Path Analysis in Weight loss, Insulin, and Metabolic Syndrome Factors ─Based on Xenical |
author_sort |
Hsiao-Feng Hsieh |
title |
The Path Analysis in Weight loss, Insulin, and Metabolic Syndrome Factors ─Based on Xenical |
title_short |
The Path Analysis in Weight loss, Insulin, and Metabolic Syndrome Factors ─Based on Xenical |
title_full |
The Path Analysis in Weight loss, Insulin, and Metabolic Syndrome Factors ─Based on Xenical |
title_fullStr |
The Path Analysis in Weight loss, Insulin, and Metabolic Syndrome Factors ─Based on Xenical |
title_full_unstemmed |
The Path Analysis in Weight loss, Insulin, and Metabolic Syndrome Factors ─Based on Xenical |
title_sort |
path analysis in weight loss, insulin, and metabolic syndrome factors ─based on xenical |
publishDate |
2011 |
url |
http://ndltd.ncl.edu.tw/handle/se9yjb |
work_keys_str_mv |
AT hsiaofenghsieh thepathanalysisinweightlossinsulinandmetabolicsyndromefactorsbasedonxenical AT xièxiǎofēng thepathanalysisinweightlossinsulinandmetabolicsyndromefactorsbasedonxenical AT hsiaofenghsieh jiǎnzhòngyǔyídǎosùjídàixièzhènghòuqúnyīnzizhīlùjìngfēnxīyǐluóshìxiānwèilì AT xièxiǎofēng jiǎnzhòngyǔyídǎosùjídàixièzhènghòuqúnyīnzizhīlùjìngfēnxīyǐluóshìxiānwèilì AT hsiaofenghsieh pathanalysisinweightlossinsulinandmetabolicsyndromefactorsbasedonxenical AT xièxiǎofēng pathanalysisinweightlossinsulinandmetabolicsyndromefactorsbasedonxenical |
_version_ |
1718626002697977856 |